AstraZeneca to report data from multiple oncology trials at ESMO 2017

AstraZeneca and its global biologics research and development arm MedImmune are set to report results of more than 40 clinical trial presentations at the European Society of Medical Oncology (ESMO) 2017 Congress to be held in Madrid, Spain, from 8-12 …
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news